Английская Википедия:Fosaprepitant

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

Fosaprepitant, sold under the brand names Emend (US) and Ivemend (EU) among others, is an antiemetic medication,[1] administered intravenously. It is a prodrug of aprepitant.

Fosaprepitant was developed by Merck & Co. and was approved for medical use in the United States,[2] and in the European Union in January 2008.[3]

References

Шаблон:Reflist

Шаблон:Antiemetics Шаблон:Neurokinin receptor modulators Шаблон:Portal bar


Шаблон:Gastrointestinal-drug-stub Шаблон:Nervous-system-drug-stub